The Lancet Infectious Diseases
The Lancet Infectious Diseases is recognized for providing a global, authoritative, and independent forum for the highest quality infectious diseases research and opinion, covering the research and treatment of diseases and conditions such as HIV/AIDS, healthcare association infections, antibiotic resistance, malaria, tuberculosis, emerging infections, and public health.
The Lancet Infectious Diseases publishes original research, reviews, personal views, commentaries, and news across the global field of infectious diseases. The journal is stringently edited and peer-reviewed to ensure the scientific merit and clinical relevance of its diverse content. All original research is fast-tracked to publication within 8 weeks on average of submission and published first online on TheLancet.com before the print issue.
With an impact factor of 17.39*, the journal ranks highest among the world's leading infectious diseases journals and has maintained this leading position every year since the journal was ranked for the first time with the 2004 Journal Citation Reports®.
Visit www.TheLancet.com to find out more about The Lancet Infectious Diseases.
* 2011 Journal Citation Reports, Thomson Reuters© 2012View all Infectious Disease titles